nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfapyridine—CYP2C9—Nilutamide—prostate cancer	0.259	0.294	CbGbCtD
Sulfapyridine—CYP2C9—Bicalutamide—prostate cancer	0.259	0.294	CbGbCtD
Sulfapyridine—CYP2C9—Estrone—prostate cancer	0.155	0.176	CbGbCtD
Sulfapyridine—CYP2C9—Capecitabine—prostate cancer	0.118	0.134	CbGbCtD
Sulfapyridine—CYP2C9—Estradiol—prostate cancer	0.0891	0.101	CbGbCtD
Sulfapyridine—Sulfamethoxazole—NAT1—prostate cancer	0.00324	0.228	CrCbGaD
Sulfapyridine—Sulfasalazine—TBXAS1—prostate cancer	0.00252	0.178	CrCbGaD
Sulfapyridine—Sulfamethoxazole—NAT2—prostate cancer	0.00102	0.0719	CrCbGaD
Sulfapyridine—Sulfathiazole—CYP19A1—prostate cancer	0.000925	0.0651	CrCbGaD
Sulfapyridine—Dapsone—NAT2—prostate cancer	0.000799	0.0562	CrCbGaD
Sulfapyridine—Sulfasalazine—CYP3A5—prostate cancer	0.000515	0.0363	CrCbGaD
Sulfapyridine—CYP2C9—Biological oxidations—UGT2B15—prostate cancer	0.00051	0.00483	CbGpPWpGaD
Sulfapyridine—Dapsone—CYP2C18—prostate cancer	0.000507	0.0357	CrCbGaD
Sulfapyridine—CYP2C9—Phase 1 - Functionalization of compounds—TBXAS1—prostate cancer	0.000504	0.00477	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—UGT2B17—prostate cancer	0.000503	0.00476	CbGpPWpGaD
Sulfapyridine—CYP2C9—Arachidonic acid metabolism—AKR1C3—prostate cancer	0.000499	0.00472	CbGpPWpGaD
Sulfapyridine—Sulfaphenazole—CYP2A6—prostate cancer	0.000488	0.0344	CrCbGaD
Sulfapyridine—CYP2C9—Biological oxidations—GSTM3—prostate cancer	0.000479	0.00454	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—SULT2B1—prostate cancer	0.000479	0.00454	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—SULT2B1—prostate cancer	0.000473	0.00448	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—GSTM3—prostate cancer	0.000473	0.00448	CbGpPWpGaD
Sulfapyridine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—prostate cancer	0.000462	0.00438	CbGpPWpGaD
Sulfapyridine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C19—prostate cancer	0.000459	0.00435	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—CYP3A43—prostate cancer	0.000454	0.0043	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—NAT1—prostate cancer	0.000454	0.0043	CbGpPWpGaD
Sulfapyridine—CYP2C9—Oxidation by Cytochrome P450—CYP2C19—prostate cancer	0.000453	0.00429	CbGpPWpGaD
Sulfapyridine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—prostate cancer	0.000449	0.00425	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—CYP3A43—prostate cancer	0.000448	0.00424	CbGpPWpGaD
Sulfapyridine—Vismodegib—CYP2C19—prostate cancer	0.000444	0.0312	CrCbGaD
Sulfapyridine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—prostate cancer	0.000443	0.00419	CbGpPWpGaD
Sulfapyridine—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—prostate cancer	0.000437	0.00414	CbGpPWpGaD
Sulfapyridine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—prostate cancer	0.000424	0.00402	CbGpPWpGaD
Sulfapyridine—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—prostate cancer	0.000419	0.00396	CbGpPWpGaD
Sulfapyridine—CYP2C9—Arachidonic acid metabolism—CYP1B1—prostate cancer	0.000413	0.00391	CbGpPWpGaD
Sulfapyridine—CYP2C9—Cytochrome P450 - arranged by substrate type—NCOA2—prostate cancer	0.000404	0.00383	CbGpPWpGaD
Sulfapyridine—CYP2C9—Arachidonic acid metabolism—GGT1—prostate cancer	0.0004	0.00379	CbGpPWpGaD
Sulfapyridine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—prostate cancer	0.00039	0.00369	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—EPHX1—prostate cancer	0.000381	0.00361	CbGpPWpGaD
Sulfapyridine—Sulfadiazine—CYP2E1—prostate cancer	0.000379	0.0267	CrCbGaD
Sulfapyridine—Dapsone—MPO—prostate cancer	0.000378	0.0266	CrCbGaD
Sulfapyridine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—prostate cancer	0.000377	0.00357	CbGpPWpGaD
Sulfapyridine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C19—prostate cancer	0.000372	0.00352	CbGpPWpGaD
Sulfapyridine—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—prostate cancer	0.000372	0.00352	CbGpPWpGaD
Sulfapyridine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—prostate cancer	0.000363	0.00344	CbGpPWpGaD
Sulfapyridine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—prostate cancer	0.000359	0.0034	CbGpPWpGaD
Sulfapyridine—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—prostate cancer	0.000359	0.00339	CbGpPWpGaD
Sulfapyridine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—prostate cancer	0.000357	0.00338	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—CYP7B1—prostate cancer	0.000353	0.00335	CbGpPWpGaD
Sulfapyridine—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	0.000352	0.00334	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—CYP7B1—prostate cancer	0.000348	0.0033	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—SULT1E1—prostate cancer	0.000344	0.00326	CbGpPWpGaD
Sulfapyridine—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	0.000344	0.00326	CbGpPWpGaD
Sulfapyridine—CYP2C9—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	0.000341	0.00323	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—SULT1E1—prostate cancer	0.00034	0.00322	CbGpPWpGaD
Sulfapyridine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	0.000336	0.00318	CbGpPWpGaD
Sulfapyridine—Dapsone—CYP3A5—prostate cancer	0.000334	0.0235	CrCbGaD
Sulfapyridine—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	0.000331	0.00314	CbGpPWpGaD
Sulfapyridine—CYP2C9—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	0.000328	0.0031	CbGpPWpGaD
Sulfapyridine—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	0.000324	0.00307	CbGpPWpGaD
Sulfapyridine—CYP2C9—Arachidonic acid metabolism—CYP1A1—prostate cancer	0.000313	0.00296	CbGpPWpGaD
Sulfapyridine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	0.000305	0.00289	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—CYP3A5—prostate cancer	0.000303	0.00287	CbGpPWpGaD
Sulfapyridine—Piroxicam—PTGS2—prostate cancer	0.000302	0.0213	CrCbGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—CYP3A5—prostate cancer	0.000299	0.00283	CbGpPWpGaD
Sulfapyridine—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—prostate cancer	0.000295	0.00279	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—GSTA3—prostate cancer	0.000293	0.00277	CbGpPWpGaD
Sulfapyridine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	0.00029	0.00274	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—GSTA3—prostate cancer	0.000289	0.00273	CbGpPWpGaD
Sulfapyridine—Vismodegib—CYP3A4—prostate cancer	0.000282	0.0199	CrCbGaD
Sulfapyridine—CYP2C9—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	0.000276	0.00261	CbGpPWpGaD
Sulfapyridine—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	0.000272	0.00258	CbGpPWpGaD
Sulfapyridine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	0.000271	0.00256	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—GSTA4—prostate cancer	0.000268	0.00254	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—TBXAS1—prostate cancer	0.000268	0.00254	CbGpPWpGaD
Sulfapyridine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	0.000267	0.00253	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—GSTA4—prostate cancer	0.000264	0.0025	CbGpPWpGaD
Sulfapyridine—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	0.000263	0.00249	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—GSTA2—prostate cancer	0.000261	0.00247	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—SULT1A1—prostate cancer	0.000258	0.00244	CbGpPWpGaD
Sulfapyridine—Sulfanilamide—CYP2E1—prostate cancer	0.000257	0.0181	CrCbGaD
Sulfapyridine—Sulfanilamide—CYP2C19—prostate cancer	0.000255	0.0179	CrCbGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—SULT1A1—prostate cancer	0.000254	0.00241	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—GSTA1—prostate cancer	0.000252	0.00238	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—GSTO1—prostate cancer	0.000249	0.00236	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—NAT2—prostate cancer	0.000249	0.00236	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—NAT2—prostate cancer	0.000246	0.00232	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—GSTO1—prostate cancer	0.000246	0.00232	CbGpPWpGaD
Sulfapyridine—Sulfadiazine—CYP3A4—prostate cancer	0.000239	0.0168	CrCbGaD
Sulfapyridine—CYP2C9—Biological oxidations—CYP2C18—prostate cancer	0.000239	0.00226	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—CYP2C18—prostate cancer	0.000235	0.00223	CbGpPWpGaD
Sulfapyridine—Dapsone—CYP2E1—prostate cancer	0.00023	0.0162	CrCbGaD
Sulfapyridine—Dapsone—CYP2C19—prostate cancer	0.000227	0.016	CrCbGaD
Sulfapyridine—CYP2C9—Biological oxidations—SULT2A1—prostate cancer	0.000222	0.0021	CbGpPWpGaD
Sulfapyridine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	0.000219	0.00208	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—SULT2A1—prostate cancer	0.000219	0.00207	CbGpPWpGaD
Sulfapyridine—Sulfasalazine—PTGS2—prostate cancer	0.000218	0.0154	CrCbGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—CBR1—prostate cancer	0.000211	0.00199	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	0.000211	0.00199	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—GPX3—prostate cancer	0.000209	0.00198	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—HPGDS—prostate cancer	0.000199	0.00188	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—CYP2C19—prostate cancer	0.000198	0.00187	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—CYP2C19—prostate cancer	0.000195	0.00185	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—GSTT1—prostate cancer	0.000193	0.00183	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—CYP2A6—prostate cancer	0.000191	0.00181	CbGpPWpGaD
Sulfapyridine—CYP2C9—Arachidonic acid metabolism—PTGS2—prostate cancer	0.000186	0.00176	CbGpPWpGaD
Sulfapyridine—Sulfamethoxazole—CYP3A4—prostate cancer	0.000185	0.013	CrCbGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	0.000184	0.00174	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—AKR1C3—prostate cancer	0.000183	0.00173	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—CYP17A1—prostate cancer	0.000183	0.00173	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—CYP17A1—prostate cancer	0.00018	0.00171	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	0.000174	0.00165	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	0.000174	0.00165	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	0.000174	0.00165	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—NCOA2—prostate cancer	0.000174	0.00165	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	0.000166	0.00158	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—CYP2E1—prostate cancer	0.000162	0.00154	CbGpPWpGaD
Sulfapyridine—Sulfanilamide—CYP3A4—prostate cancer	0.000162	0.0114	CrCbGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—CYP2E1—prostate cancer	0.00016	0.00151	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—CYP3A4—prostate cancer	0.000156	0.00148	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—CYP3A4—prostate cancer	0.000154	0.00146	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—CYP1B1—prostate cancer	0.000154	0.00146	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—CYP1B1—prostate cancer	0.000152	0.00144	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—GGT1—prostate cancer	0.000149	0.00141	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	0.000148	0.0014	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—NCOA1—prostate cancer	0.000147	0.00139	CbGpPWpGaD
Sulfapyridine—Dapsone—CYP3A4—prostate cancer	0.000145	0.0102	CrCbGaD
Sulfapyridine—CYP2C9—Biological oxidations—CYP19A1—prostate cancer	0.000145	0.00137	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—CYP19A1—prostate cancer	0.000143	0.00135	CbGpPWpGaD
Sulfapyridine—Dapsone—PTGS2—prostate cancer	0.000142	0.00997	CrCbGaD
Sulfapyridine—CYP2C9—Biological oxidations—RXRA—prostate cancer	0.00014	0.00132	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	0.000139	0.00132	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	0.000136	0.00128	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—COMT—prostate cancer	0.000134	0.00127	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—GSTP1—prostate cancer	0.000134	0.00127	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—COMT—prostate cancer	0.000133	0.00126	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	0.000132	0.00125	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—GSTP1—prostate cancer	0.000132	0.00125	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	0.000126	0.00119	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	0.000126	0.00119	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—GSTM1—prostate cancer	0.000123	0.00116	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—GSTM1—prostate cancer	0.000121	0.00115	CbGpPWpGaD
Sulfapyridine—CYP2C9—Biological oxidations—CYP1A1—prostate cancer	0.000117	0.0011	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—HAO1—prostate cancer	0.000115	0.00109	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metapathway biotransformation—CYP1A1—prostate cancer	0.000115	0.00109	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	0.000107	0.00102	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	0.000103	0.000973	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	9.9e-05	0.000937	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	9.56e-05	0.000905	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CBR1—prostate cancer	9.38e-05	0.000888	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—ADI1—prostate cancer	9.38e-05	0.000888	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—TST—prostate cancer	9.38e-05	0.000888	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—PSAT1—prostate cancer	9.38e-05	0.000888	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—GRHL1—prostate cancer	9.38e-05	0.000888	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CSAD—prostate cancer	9.38e-05	0.000888	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	9.17e-05	0.000868	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	8.99e-05	0.000851	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CKMT2—prostate cancer	8.72e-05	0.000825	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—UGT2B15—prostate cancer	8.72e-05	0.000825	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—UGT2B17—prostate cancer	8.72e-05	0.000825	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—GRHPR—prostate cancer	8.72e-05	0.000825	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	8.52e-05	0.000807	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—prostate cancer	8.38e-05	0.000794	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—GSTM3—prostate cancer	8.2e-05	0.000776	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—PGAM2—prostate cancer	8.2e-05	0.000776	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—AOX1—prostate cancer	8.2e-05	0.000776	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—NAGLU—prostate cancer	8.2e-05	0.000776	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—RFK—prostate cancer	8.2e-05	0.000776	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—MBTPS1—prostate cancer	8.2e-05	0.000776	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—SULT2B1—prostate cancer	8.2e-05	0.000776	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	8.01e-05	0.000758	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—AMACR—prostate cancer	7.77e-05	0.000736	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CYP3A43—prostate cancer	7.77e-05	0.000736	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—DEGS1—prostate cancer	7.77e-05	0.000736	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—NAT1—prostate cancer	7.77e-05	0.000736	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—SRD5A2—prostate cancer	7.77e-05	0.000736	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	7.64e-05	0.000724	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	7.59e-05	0.000719	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—HSD17B1—prostate cancer	7.41e-05	0.000702	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	7.41e-05	0.000702	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	7.13e-05	0.000675	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	7.09e-05	0.000671	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	7.02e-05	0.000664	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	6.69e-05	0.000633	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—HPGD—prostate cancer	6.61e-05	0.000625	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—B4GALT4—prostate cancer	6.61e-05	0.000625	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—TNFRSF21—prostate cancer	6.21e-05	0.000588	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CYP7B1—prostate cancer	6.04e-05	0.000572	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—MTAP—prostate cancer	6.04e-05	0.000572	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	5.91e-05	0.000559	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—SULT1E1—prostate cancer	5.89e-05	0.000557	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—SRD5A1—prostate cancer	5.89e-05	0.000557	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	5.72e-05	0.000542	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	5.63e-05	0.000533	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—HSD17B3—prostate cancer	5.62e-05	0.000532	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—ACSL4—prostate cancer	5.62e-05	0.000532	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	5.55e-05	0.000526	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—ARG2—prostate cancer	5.39e-05	0.00051	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—PHGDH—prostate cancer	5.39e-05	0.00051	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—UMPS—prostate cancer	5.39e-05	0.00051	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	5.36e-05	0.000507	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—LDHB—prostate cancer	5.28e-05	0.0005	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CYP3A5—prostate cancer	5.18e-05	0.000491	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—PDHA1—prostate cancer	5.01e-05	0.000474	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—GSTA3—prostate cancer	5.01e-05	0.000474	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—TCN2—prostate cancer	5.01e-05	0.000474	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—UCP3—prostate cancer	5.01e-05	0.000474	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—SLC22A3—prostate cancer	4.78e-05	0.000452	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—HSD3B1—prostate cancer	4.78e-05	0.000452	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	4.63e-05	0.000439	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—TBXAS1—prostate cancer	4.58e-05	0.000434	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—GSTA4—prostate cancer	4.58e-05	0.000434	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	4.48e-05	0.000424	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—GSTA2—prostate cancer	4.46e-05	0.000422	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—ABCG5—prostate cancer	4.41e-05	0.000417	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—SULT1A1—prostate cancer	4.41e-05	0.000417	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—GSTA1—prostate cancer	4.31e-05	0.000408	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—NAT2—prostate cancer	4.26e-05	0.000403	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—HSD3B2—prostate cancer	4.26e-05	0.000403	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—GSTO1—prostate cancer	4.26e-05	0.000403	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	4.09e-05	0.000388	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—PLCB2—prostate cancer	4.08e-05	0.000386	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—LRP2—prostate cancer	4.08e-05	0.000386	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CYP2C18—prostate cancer	4.08e-05	0.000386	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—P4HB—prostate cancer	4e-05	0.000379	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—SLC22A1—prostate cancer	3.89e-05	0.000369	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.85e-05	0.000364	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—SULT2A1—prostate cancer	3.79e-05	0.000359	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—MED12—prostate cancer	3.73e-05	0.000353	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—GNG5—prostate cancer	3.7e-05	0.000351	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—NCOA3—prostate cancer	3.57e-05	0.000338	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.51e-05	0.000332	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—HPGDS—prostate cancer	3.4e-05	0.000322	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CYP2C19—prostate cancer	3.38e-05	0.00032	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—ACHE—prostate cancer	3.3e-05	0.000313	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—GSTT1—prostate cancer	3.3e-05	0.000313	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CYP2A6—prostate cancer	3.26e-05	0.000309	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.25e-05	0.000308	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—AKR1C3—prostate cancer	3.17e-05	0.000301	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—PRKACB—prostate cancer	3.16e-05	0.000299	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CYP17A1—prostate cancer	3.12e-05	0.000296	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.08e-05	0.000292	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—NCOA2—prostate cancer	2.98e-05	0.000282	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.84e-05	0.000269	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.77e-05	0.000263	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—NQO1—prostate cancer	2.74e-05	0.00026	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—TH—prostate cancer	2.7e-05	0.000256	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.69e-05	0.000254	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.68e-05	0.000253	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.66e-05	0.000252	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.63e-05	0.000249	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—GGT1—prostate cancer	2.55e-05	0.000241	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—NCOA1—prostate cancer	2.51e-05	0.000238	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.47e-05	0.000234	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—RXRA—prostate cancer	2.39e-05	0.000226	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.32e-05	0.00022	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—COMT—prostate cancer	2.3e-05	0.000218	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—GSTP1—prostate cancer	2.29e-05	0.000217	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—ITPR1—prostate cancer	2.25e-05	0.000213	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.21e-05	0.00021	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—TYMS—prostate cancer	2.13e-05	0.000201	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—GSTM1—prostate cancer	2.1e-05	0.000199	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—LPL—prostate cancer	2.06e-05	0.000195	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.99e-05	0.000189	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—ERCC2—prostate cancer	1.98e-05	0.000187	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—MTHFR—prostate cancer	1.86e-05	0.000176	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—PPARA—prostate cancer	1.82e-05	0.000173	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CAV1—prostate cancer	1.71e-05	0.000162	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.64e-05	0.000155	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.56e-05	0.000148	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—INS—prostate cancer	1.48e-05	0.00014	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—CREBBP—prostate cancer	1.45e-05	0.000137	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.37e-05	0.00013	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—NOS3—prostate cancer	1.3e-05	0.000123	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.2e-05	0.000113	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—PTGS2—prostate cancer	1.19e-05	0.000112	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—PTEN—prostate cancer	1.03e-05	9.79e-05	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—EP300—prostate cancer	9.86e-06	9.33e-05	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—PIK3CA—prostate cancer	7.29e-06	6.9e-05	CbGpPWpGaD
Sulfapyridine—CYP2C9—Metabolism—AKT1—prostate cancer	5.96e-06	5.64e-05	CbGpPWpGaD
